Correlation Between Vincerx Pharma and CAMP4 THERAPEUTICS

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Vincerx Pharma and CAMP4 THERAPEUTICS at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Vincerx Pharma and CAMP4 THERAPEUTICS into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Vincerx Pharma and CAMP4 THERAPEUTICS PORATION, you can compare the effects of market volatilities on Vincerx Pharma and CAMP4 THERAPEUTICS and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Vincerx Pharma with a short position of CAMP4 THERAPEUTICS. Check out your portfolio center. Please also check ongoing floating volatility patterns of Vincerx Pharma and CAMP4 THERAPEUTICS.

Diversification Opportunities for Vincerx Pharma and CAMP4 THERAPEUTICS

0.16
  Correlation Coefficient

Average diversification

The 3 months correlation between Vincerx and CAMP4 is 0.16. Overlapping area represents the amount of risk that can be diversified away by holding Vincerx Pharma and CAMP4 THERAPEUTICS PORATION in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CAMP4 THERAPEUTICS and Vincerx Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Vincerx Pharma are associated (or correlated) with CAMP4 THERAPEUTICS. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CAMP4 THERAPEUTICS has no effect on the direction of Vincerx Pharma i.e., Vincerx Pharma and CAMP4 THERAPEUTICS go up and down completely randomly.

Pair Corralation between Vincerx Pharma and CAMP4 THERAPEUTICS

Given the investment horizon of 90 days Vincerx Pharma is expected to under-perform the CAMP4 THERAPEUTICS. But the stock apears to be less risky and, when comparing its historical volatility, Vincerx Pharma is 1.3 times less risky than CAMP4 THERAPEUTICS. The stock trades about -0.43 of its potential returns per unit of risk. The CAMP4 THERAPEUTICS PORATION is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  541.00  in CAMP4 THERAPEUTICS PORATION on December 28, 2024 and sell it today you would lose (99.00) from holding CAMP4 THERAPEUTICS PORATION or give up 18.3% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy98.36%
ValuesDaily Returns

Vincerx Pharma  vs.  CAMP4 THERAPEUTICS PORATION

 Performance 
       Timeline  
Vincerx Pharma 

Risk-Adjusted Performance

Very Weak

 
Weak
 
Strong
Over the last 90 days Vincerx Pharma has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of unfluctuating performance in the last few months, the Stock's basic indicators remain rather sound which may send shares a bit higher in April 2025. The latest tumult may also be a sign of longer-term up-swing for the firm shareholders.
CAMP4 THERAPEUTICS 

Risk-Adjusted Performance

Weak

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in CAMP4 THERAPEUTICS PORATION are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Even with relatively inconsistent primary indicators, CAMP4 THERAPEUTICS reported solid returns over the last few months and may actually be approaching a breakup point.

Vincerx Pharma and CAMP4 THERAPEUTICS Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Vincerx Pharma and CAMP4 THERAPEUTICS

The main advantage of trading using opposite Vincerx Pharma and CAMP4 THERAPEUTICS positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Vincerx Pharma position performs unexpectedly, CAMP4 THERAPEUTICS can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CAMP4 THERAPEUTICS will offset losses from the drop in CAMP4 THERAPEUTICS's long position.
The idea behind Vincerx Pharma and CAMP4 THERAPEUTICS PORATION pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Stocks Directory
Find actively traded stocks across global markets
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios